Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Head and Neck Malignancy: Is PET/CT More Accurate than PET or CT Alone?
330
Zitationen
7
Autoren
2005
Jahr
Abstract
PURPOSE: To prospectively determine whether combined positron emission tomography (PET) and computed tomography (CT) is more accurate than either PET or CT alone in depicting malignant lesions in the head and neck. MATERIALS AND METHODS: Study was approved by the institutional review board, and patient informed consent was waived. Sixty-five consecutive patients (42 men, 23 women; age range, 43-83 years) known to have or suspected of having head and neck cancer were examined with combined PET/CT. CT was performed with intravenous administration of a contrast agent, and the CT data were used for attenuation correction. Each examination was interpreted in three ways: PET images in the absence of CT data, CT images in the absence of PET data, and fused PET/CT images. Probability of malignancy of each lesion was assigned a score by using a five-point scale. Receiver operating characteristic (ROC) analyses were performed by using biopsy, imaging, or clinical follow-up as the reference standard. The minimum follow-up was 6 months (range, 6-12 months). The results were additionally analyzed to assess the degree of radiologist confidence. RESULTS: Follow-up was available for 64 (98%) of 65 patients. ROC analyses demonstrated that PET/CT is significantly superior to PET or CT alone for depiction of malignancy in the head and neck (P < .05). In this series, PET/CT had a sensitivity of 98%, a specificity of 92%, and an accuracy of 94%. Radiologist confidence was substantially higher with the combined modality. CONCLUSION: Combined PET/CT is more accurate than PET or CT alone for the depiction of malignancy in the head and neck. Radiologist confidence is improved with the combined modality.
Ähnliche Arbeiten
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 · 6.462 Zit.
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 · 6.273 Zit.
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 · 5.087 Zit.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
2016 · 5.002 Zit.
Head and neck squamous cell carcinoma
2020 · 3.929 Zit.